New eye injection trial aims to halt vision loss
Disease control
Recruiting now
This study is testing a new eye injection called EYE103 for people with two conditions that cause vision loss: wet age-related macular degeneration and swelling after a retinal vein blockage. 160 participants will receive three injections into their eye over 12 weeks to see if th…
Phase: PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC